Health Condition 1: G00-G99- Diseases of the nervous system Health Condition 2: G00-G99- Diseases of the nervous system
Conditions
Interventions
Intervention1: Krushna Churna: Group A will be treated with Krushna Churna which include Krushna (Piper
Longum
Linn)
krushna churna will be given orally in dose of 500mg with
gomutra10ml & eranda ta
Sponsors
PDEAs College of Ayurved and Research Centre Pradhikaran Nigdi Pune
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients showing classical symptoms and sign of Gridhrasi that is Padashoola (pain) ,Katishoola (pain),Stambha (stiffness) ,Toda (pricking sensation) ,Spandan (twitching) , Dehasya –Api-Pravakrata (Gait),Aruchi (Anorexia),Tandra (Drowsiness),Gaurav (Heaviness) as described in ayurvedic samhitas in Charak Chikitsasthan 28/57,58. - Radiating pain along the course and distribution of sciatic nerve that is in buttock to outer border of foot. 2. SLR Test of patient – positive upto 60 degree. 3. Patients between the age of 25-65 years. 4. Patients from all socio-economic status.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating mothers. 2. Infective disorders – T.B. spine, osteomyelitis. 3. Patients with paraplegia of lower limb. 4. Fracture of spinal bones or in lower extremity bones 5. Patients having congenital anamolies with lumbosacral spine such as kyphosis, scolisis. 6. Patients having any major chronic/acute; systemic/surgical pathology like malignancies. 7. Patients with deep wounds penetrating till sciatic nerve. 8. Patients with dislocation of hip joint, amputation above knee joint. 9. Patient having symptoms caused by prolonged pressure on hip like comatosed patients. 10.Patients having allergy to any content of drugs. 11. High risk (above 65 years age, known cases of HTN, DM,COPD) comorbid patients suspected for covid 19. Suspected covid 19 patient having symptoms as per ICMR guidelines.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare efficacy of krushna churna at vynodan kal with gomutra10ml & eranda tail 5 ml For 1month & parijatak gugulu 500 mg tab at vyonodan kal with koshna jal for 1 month in the management of GridhrasiTimepoint: One month with follow up on 7th 14th 21st and 28th day | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To compare and study the efficacy of krushna churna. 2. To compare and study the efficacy of Parijatak Gugulu. 3. To study adverse effect if anyTimepoint: One month with follow up on 7th 14th 21st and 28th day | — |
Countries
India
Contacts
Public ContactPrashant Dhondiram Chavan
PDEAS college of ayurved and research center pradhikaran nigdi pune
Outcome results
None listed